Movement Disorders · 2012 · 115 citations · 22 references
Life SciencesGeneticsNeurologyCognitive NeurologyNeurodegenerationNeurogeneticsCognitive ImpairmentCognitive SymptomsNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersParkinson DiseaseCognitive Impairment AssociationsCognitive Motor AssessmentGaucher DiseaseNeurodegeneration GeneticsNeurodegeneration PathogenesisNeurodegenerative Disease-associated Smell LossNeurodegenerative GeneticsOlfactory Function Assessment
The objective of this study was to assess a cohort of Gaucher disease patients and their heterozygous carrier relatives for potential clinical signs of early neurodegeneration. Gaucher disease patients (n = 30), heterozygous glucocerebrosidase mutation carriers (n = 30), and mutation-negative controls matched by age, sex, and ethnicity (n = 30) were recruited. Assessment was done for olfactory function (University of Pennsylvania Smell Identification Test), cognitive function (Mini-Mental State Examination, Montreal Cognitive Assessment), rapid eye movement sleep disorder, autonomic symptoms, and parkinsonian motor signs (Unified Parkinson's Disease Rating Scale part III, Purdue pegboard). Olfactory function scores were significantly lower in Gaucher disease patients (P = .010) and heterozygous carriers (P < .001) than in controls. Cognitive assessment scores were significantly lower in Gaucher disease patients (P = .002) and carriers (P = .002) than in controls. Unified Parkinson's Disease Rating Scale motor subscale scores were significantly higher in Gaucher disease patients (P < .001) and heterozygotes (P = .0010) than in controls. There was no difference in scores for symptoms of rapid eye movement sleep disorder or autonomic dysfunction. Impairment of olfaction, cognition, and parkinsonian motor signs occurs more frequently in Gaucher disease patients and carriers than in controls, which may indicate the early stages of neurodegeneration.
22
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky, Mike A. Nalls, Jan Aasly et al. · New England Journal of Medicine · 2009 · 2.1K citations · Full text
Joseph R. Mazzulli, You-Hai Xu, Ying Sun et al. · Cell · 2011 · 1.3K citations · Full text
The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument
Karin Stiasny‐Kolster, Geert Mayer, Sylvia Schäfer et al. · Movement Disorders · 2007 · 1.1K citations
Medicine, Neurology, Neuroscience +17
John C. Dalrymple‐Alford, Michael R. MacAskill, Christos T. Nakas et al. · Neurology · 2010 · 950 citations
Association of olfactory dysfunction with risk for future Parkinson's disease
G. Webster Ross, Helen Petrovitch, Robert D. Abbott et al. · Annals of Neurology · 2007 · 744 citations
Medicine, Neurology, Neuroscience +16